Show simple item record

dc.contributor.authorMezones-Holguin, E.
dc.contributor.authorAl-kassab-Córdova, A.
dc.contributor.authorMaguiña, J.L.
dc.contributor.authorRodriguez-Morales, A.J.
dc.date.accessioned2025-10-31T18:32:55Z
dc.date.available2025-10-31T18:32:55Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/20.500.12805/4812
dc.description.abstractPeru has one of the most comprehensive immunization programs in the Latin-America, financed 100% by public resources under regulation of the Ministry of Health (MINSA). This free-of-charge schedule includes 17 vaccines that protect against around 26 diseases and reaches pregnant women and the elderly, although the primary target population is children under five-years-old.en_US
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofurn:issn:1477-8939
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectVaccine Hesitancy and Measles Immunization Challengesen_US
dc.subjectVaccine Hesitancy and Public Health Dynamicsen_US
dc.titleVaccination coverage and preventable diseases in Peru: Reflections on the first diphtheria case in two decades during the midst of COVID-19 pandemicen_US
dc.typehttps://purl.org/coar/resource_type/c_545b
dc.identifier.doihttps://doi.org/10.1016/j.tmaid.2020.101956
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.05
dc.type.otherLetter to the editor
dc.identifier.journalTravel Medicine and Infectious Disease
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2